Quick Answer
Pacira BioSciences, Inc. reported Net Income Loss of $7.03 million for the year ending 2025.
- Pacira BioSciences, Inc. showed an increase of +107.1% in Net Income Loss from 2024 to 2025.
- This data is from Pacira BioSciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Pacira BioSciences, Inc.'s Net Income Loss has grown by 122.2%.
- Historical annual values: Fiscal year 2025: $7.03 million | Fiscal year 2024: -$99.56 million | Fiscal year 2023: $41.96 million | Fiscal year 2022: $15.91 million | Fiscal year 2021: $41.98 million | Fiscal year 2020: $145.52 million | Fiscal year 2019: -$11.02 million | Fiscal year 2018: -$471.0 thousand | Fiscal year 2017: -$42.61 million | Fiscal year 2016: -$37.95 million | Fiscal year 2015: $1.86 million | Fiscal year 2014: -$13.72 million | Fiscal year 2013: -$63.91 million | Fiscal year 2012: -$52.28 million | Fiscal year 2011: -$43.33 million | Fiscal year 2010: -$27.15 million | Fiscal year 2009: -$31.71 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: